AEterna Zentaris Inc. (AEZS)

[skitahoe]

It's my belief that the Japanese authorities won't approve a drug without trials performed on sufficient Japanese patients to verify it works with them. I believe they continue a trial in colon cancer in spite of the failure by KERX, I'm uncertain if the protocol is identical.

The fact that they'll invest further funds should be seen as a positive. I'm uncertain that they must go all the way throught Phase III in Japan if FDA approval occurs, but clearly they won't approve on U.S. data alone.

Gary